ペンシルベニアにおける皮膚筋炎の臨床試験
ペンシルベニア内の拠点で、皮膚筋炎に関する7件の研究が参加者を募集しています。
ペンシルベニア内の都市
公式研究テキスト（英語）
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Philadelphia
- Research Site, Pittsburgh
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/09/24更新 · NCT06455449Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Children's Hospital of Philadelphia - Accepting Young Adult and Juvenile Patients, Philadelphia
- UPMC Children's Hospital of Pittsburgh - Accepting Juvenile Patients, Pittsburgh
- UPMC Arthritis and Autoimmunity Center - Accepting Adult Patients, Pittsburgh
被験者募集中第2/3相
6歳〜75歳 · 全性別 · 2026/09/17更新 · NCT06154252A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- UPMC Arthritis and Autoimmunity Center, Falk Clinic, Pittsburgh
- UPMC Montefiore Clinical and Translational Research Center (CTRC), Pittsburgh
- UPMC Presbyterian Shadyside Hospital, Pittsburgh
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT05895786Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia
被験者募集中第1相
18歳〜85歳 · 全性別 · 2026/07/22更新 · NCT06371417Intralesional Injection of STS in Treatment of Calcinosis
- UPMC Arthritis and Autoimmunity Center, Pittsburgh
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/05更新 · NCT06672822Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)
- Hospital of the University of Pennsylvania, Philadelphia
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/30更新 · NCT02945345ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。